Ranbaxy announced the launch of Absorica (isotretinoin) 25mg and 35mg capsules for the treatment of severe recalcitrant nodular acne in patients ≥12 years old.

Absorica is a retinoid that inhibits sebaceous gland function and keratinization. Clinical improvement in nodular acne patients occurs in association with a reduction in sebum secretion. The decrease in sebum secretion is temporary and is related to the dose and duration of treatment with isotretinoin and reflects a reduction in sebaceous gland size and an inhibition of sebaceous gland differentiation.

RELATED: Acne Patient Information Fact Sheet

Absorica is already available in 10mg, 20mg, 30mg, and 40mg strength capsules. All strengths are available in 30-count bottles.

For more information call (800) 406-7984 or visit Ranbaxy.com.